Novel anti-cancer targets
Small GTPases are proteins that switch between an inactive and an active state, triggering signalling cascades in cells. They are involved in many physiological processes such as vesicle trafficking but also in cancer, mediating pre-metastatic niche formation. The EU-funded RabTarget4Metastasis project is focussing on the development of inhibitors against the Rab27A GTPase hoping to effectively reduce and prevent cancer metastasis. Two regions in the protein will serve as the starting point for the development of selective inhibitors which will be tested for their ability to disrupt Rab27A activity in cancer cells. Evaluation of the therapeutic potential of the lead compounds that emerge from this work may open new avenues in cancer treatment.
Call for proposal
See other projects for this call